Hypertension in infantile polycystic renal disease. The importance of early recognition and treatment of severe hypertension in polycystic renal disease.
D000535:Aluminum / Q000627:therapeutic use; D002675:Child, Preschool; D005919:Glomerular Filtration Rate; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006878:Hydroxides / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D007223:Infant; D007231:Infant, Newborn; D007668:Kidney / Q000503:physiopathology; D007674:Kidney Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D014511:Uremia / Q000209:etiology
D006878:Hydroxides; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D000535:Aluminum